Sang Yoon Lee1, Han-Gil Seo, Nam-Jong Paik. 1. Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seoul, South Korea.
Abstract
OBJECTIVE: To evaluate the effect of botulinum toxin type A injections on dysphagia accompanied by upper esophageal sphincter dysfunction. DESIGN: A preinjection and postinjection blinded retrospective review was performed using the videofluoroscopic swallowing study video clips of eight patients administered botulinum toxin type A because of dysphagia with accompanying upper esophageal sphincter dysfunction at a dysphagia clinic in a department of rehabilitation medicine at a university hospital. The outcome variables applied were a functional dysphagia scale that included assessments of food residues in vallecula and piriform sinuses, and bolus transit time, and physician's judgment regarding which videos (preinjection or postinjection) were functionally superior in terms of aspiration frequency and bolus transit time. RESULTS: After botulinum toxin type A injection, residues in the piriform sinus significantly improved (P < 0.05), and the applied functional dysphagia scale showed a tendency toward improvement (P = 0.173). A blinded physician found postinjection to be superior to preinjection in terms of videofluoroscopic swallowing study results in six of eight cases. CONCLUSIONS: Botulinum toxin type A injection to the upper esophageal sphincter was found to improve swallowing function in patients with upper esophageal sphincter dysfunction and seems to offer a possible therapeutic option in these patients.
OBJECTIVE: To evaluate the effect of botulinum toxin type A injections on dysphagia accompanied by upper esophageal sphincter dysfunction. DESIGN: A preinjection and postinjection blinded retrospective review was performed using the videofluoroscopic swallowing study video clips of eight patients administered botulinum toxin type A because of dysphagia with accompanying upper esophageal sphincter dysfunction at a dysphagia clinic in a department of rehabilitation medicine at a university hospital. The outcome variables applied were a functional dysphagia scale that included assessments of food residues in vallecula and piriform sinuses, and bolus transit time, and physician's judgment regarding which videos (preinjection or postinjection) were functionally superior in terms of aspiration frequency and bolus transit time. RESULTS: After botulinum toxin type A injection, residues in the piriform sinus significantly improved (P < 0.05), and the applied functional dysphagia scale showed a tendency toward improvement (P = 0.173). A blinded physician found postinjection to be superior to preinjection in terms of videofluoroscopic swallowing study results in six of eight cases. CONCLUSIONS: Botulinum toxin type A injection to the upper esophageal sphincter was found to improve swallowing function in patients with upper esophageal sphincter dysfunction and seems to offer a possible therapeutic option in these patients.